Company
Views ML
TRANSFORMING PRECISION MEDICINE AND DIAGNOSTICS WITH VIRTUAL BIOMARKER STAINING
Also known as ViewsML
- Status
- Operatingas of 2026-09-23
- Business model
- B2B
- Customers
- biopharmaceutical companies, tissue banks, clinical laboratories, academic institutions, and CROs
- Legal name
- ViewsML Technologies Inc.
Claim, correct or request removal
Record updated 23 September 2026
About
ViewsML is dedicated to leveraging the power of AI to accelerate the delivery of precision medicines and make them accessible to patients worldwide.
Funding snapshot
- Total raised
- $4.9MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Undisclosed, $4.9M2026-04-20
Funding rounds
- Round, 2026
- $4.9M2026-04-20, Company stated
Products
- Other
- Virtual Biomarker Staining Platform
Loading relationship preview